Michaela Medová (Michaela Medova)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 16

Top Venues

Cancer research communications

Biomedicines

Oncogene

Cell death & disease

Inselspital Bern Universitätsklinik für Radio-Onkologie

University of Bern (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Inselspital Bern Universitätsklinik für Radio-Onkologie Jan 01 2013

Switzerland

Group Leader :: Radiation Oncology

University of Bern Jan 01 2011 - Dec 01 2012

Switzerland

Postdoctoral Fellow :: Department of Clinical Research

Education History

University of Bern Dec 01 2006 - Dec 10 2010

Switzerland

PHD :: Department of Clinical Research

Comenius University Sep 01 2001 - Jun 19 2006

Slovakia

MSC :: Biophysics

Comenius University Sep 10 2001 - Jun 02 2006

Slovakia

MSC :: Journalism

Publications

Michaela Poliaková Turan, Rahel Riedo, Matúš Medo, Chiara Pozzato, Manja Friese-Hamim, Jonas Paul Koch, Si'Ana A Coggins, Qun Li, Baek Kim, Joachim Albers, Daniel Matthias Aebersold, Nicola Zamboni, Yitzhak Zimmer, Michaela Medová
E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network. Cancer research communications 4 (7) (2024)
Michaela Poliaková Turan, Rahel Riedo, Matúš Medo, Chiara Pozzato, Manja Friese-Hamim, Jonas Paul Koch, Si'Ana A Coggins, Qun Li, Baek Kim, Joachim Albers, Daniel Matthias Aebersold, Nicola Zamboni, Yitzhak Zimmer, Michaela Medová
E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network. Cancer research communications 4 (7) (2024)
Michaela Poliaková Turan, Rahel Riedo, Matúš Medo, Chiara Pozzato, Manja Friese-Hamim, Jonas Paul Koch, Si'Ana A Coggins, Qun Li, Baek Kim, Joachim Albers, Daniel Matthias Aebersold, Nicola Zamboni, Yitzhak Zimmer, Michaela Medová
E2F1-associated purine synthesis pathway is a major component of the MET-DNA damage response network. Cancer research communications (2024)
Michaela Poliaková Turan, Rahel Riedo, Matúš Medo, Chiara Pozzato, Manja Friese-Hamim, Jonas Paul Koch, Si'Ana A Coggins, Qun Li, Baek Kim, Joachim Albers, Daniel Matthias Aebersold, Nicola Zamboni, Yitzhak Zimmer, Michaela Medová
E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network. Cancer research communications 4 (7) (2024)
Jonas Paul Koch, Selina M Roth, Aurélie Quintin, Jacopo Gavini, Eleonora Orlando, Rahel Riedo, Chiara Pozzato, Liana Hayrapetyan, Ruedi Aebersold, Deborah M Stroka, Daniel M Aebersold, Matúš Medo, Yitzhak Zimmer, Michaela Medová
A DNA-PK phosphorylation site on MET regulates its signaling interface with the DNA damage response. Oncogene (2023)
Daniel H Schanne, Alexander Koch, Olgun Eliçin, Roland Giger, Michaela Medová, Yitzhak Zimmer, Daniel Matthias Aebersold
Prognostic and Predictive Biomarkers in Head and Neck Squamous Cell Carcinoma Treated with Radiotherapy-A Systematic Review. Biomedicines 10 (12) (2022)
Daniel H Schanne, Alexander Koch, Olgun Eliçin, Roland Giger, Michaela Medová, Yitzhak Zimmer, Daniel Matthias Aebersold
Prognostic and Predictive Biomarkers in Head and Neck Squamous Cell Carcinoma Treated with Radiotherapy-A Systematic Review. Biomedicines 10 (12) (2022)
Nicolas Melin, Daniel Sánchez-Taltavull, René Fahrner, Adrian Keogh, Michel Dosch, Isabel Büchi, Yitzhak Zimmer, Michaela Medová, Guido Beldi, Daniel M Aebersold, Daniel Candinas, Deborah M Stroka
Synergistic effect of the TLR5 agonist CBLB502 and its downstream effector IL-22 against liver injury. Cell death & disease 12 (4) (2021)
Noëlle Dommann, Daniel Sánchez-Taltavull, Linda Eggs, Fabienne Birrer, Tess Brodie, Lilian Salm, Felix Alexander Baier, Michaela Medová, Magali Humbert, Mario P Tschan, Guido Beldi, Daniel Candinas, Deborah Stroka
The LIM Protein Ajuba Augments Tumor Metastasis in Colon Cancer. Cancers 12 (7) (2020)
Jonas P Koch, Daniel M Aebersold, Yitzhak Zimmer, Michaela Medová
MET targeting: time for a rematch. Oncogene 39 (14) (2020)
Ariel Bensimon, Jonas P Koch, Paola Francica, Selina M Roth, Rahel Riedo, Astrid A Glück, Eleonora Orlando, Andree Blaukat, Daniel M Aebersold, Yitzhak Zimmer, Ruedi Aebersold, Michaela Medová
Deciphering MET-dependent modulation of global cellular responses to DNA damage by quantitative phosphoproteomics. Molecular oncology 14 (6) (2020)
Jacopo Gavini, Noëlle Dommann, Manuel O Jakob, Adrian Keogh, Laure C Bouchez, Sofia Karkampouna, Marianna Kruithof-de Julio, Michaela Medová, Yitzhak Zimmer, Anna M Schläfli, Mario P Tschan, Daniel Candinas, Deborah Stroka, Vanessa Banz
Verteporfin-induced lysosomal compartment dysregulation potentiates the effect of sorafenib in hepatocellular carcinoma. Cell death & disease 10 (10) (2019)
Michaela Poliaková, Andrea Felser, Katarzyna Pierzchala, Jean-Marc Nuoffer, Daniel Matthias Aebersold, Yitzhak Zimmer, Nicola Zamboni, Michaela Medová
Metabolomics reveals tepotinib-related mitochondrial dysfunction in MET-activating mutations-driven models. The FEBS journal 286 (14) (2019)
Lluís Nisa, Paola Francica, Roland Giger, Matúš Medo, Olgun Eliçin, Manja Friese-Hamim, Claudia Wilm, Christopher Stroh, Beat Bojaxhiu, Aurélie Quintin, Marco D Caversaccio, Matthias S Dettmer, Mélanie Buchwalder, Tess M Brodie, Daniel Matthias Aebersold, Yitzhak Zimmer, Thomas E Carey, Michaela Medová
Targeting the MET Receptor Tyrosine Kinase as a Strategy for Radiosensitization in Locoregionally Advanced Head and Neck Squamous Cell Carcinoma. Molecular cancer therapeutics 19 (2) (2019)
Lluís Nisa, David Barras, Michaela Medová, Daniel M Aebersold, Matúš Medo, Michaela Poliaková, Jonas Koch, Beat Bojaxhiu, Olgun Eliçin, Matthias S Dettmer, Paolo Angelino, Roland Giger, Urs Borner, Marco D Caversaccio, Thomas E Carey, Liza Ho, Thomas A McKee, Mauro Delorenzi, Yitzhak Zimmer
Comprehensive Genomic Profiling of Patient-matched Head and Neck Cancer Cells: A Preclinical Pipeline for Metastatic and Recurrent Disease. Molecular cancer research : MCR 16 (12) (2018)
Michaela Poliaková, Daniel M Aebersold, Yitzhak Zimmer, Michaela Medová
The relevance of tyrosine kinase inhibitors for global metabolic pathways in cancer. Molecular cancer 17 (1) (2018)

Michaela Medová.css-eqlu8i{font-size:small;padding-left:4px;} (Michaela Medova)

Publication Activity (10 Years)

Top Topics

Top Venues

Michaela Medová (Michaela Medova)